These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10779474)

  • 1. Methylenetetrahydrofolate reductase gene and coronary artery disease.
    Mager A
    Circulation; 2000 Apr; 101(16):E172-3. PubMed ID: 10779474
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperhomocysteinemia, MTHFR, and risk of vascular disease.
    Blom HJ; Verhoef DP
    Circulation; 2000 Apr; 101(16):E171; author reply E173. PubMed ID: 10779473
    [No Abstract]   [Full Text] [Related]  

  • 3. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis.
    Brattström L; Wilcken DE; Ohrvik J; Brudin L
    Circulation; 1998 Dec; 98(23):2520-6. PubMed ID: 9843457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced frequency of the thermolabile methylenetetrahydrofolate reductase genotype in the elderly.
    Kluijtmans LA; Whitehead AS
    Atherosclerosis; 1999 Oct; 146(2):395-7. PubMed ID: 10532696
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].
    Spiridonova MG; Stepanov VA; Puzyrev VP
    Klin Med (Mosk); 2001; 79(2):10-6. PubMed ID: 11419077
    [No Abstract]   [Full Text] [Related]  

  • 6. Common mutation in the methylenetetrahydrofolate reductase gene offers no support for mild hyperhomocysteinemia being a causal risk factor for cardiovascular disease.
    Brattström L
    Circulation; 1997 Nov; 96(10):3805-7. PubMed ID: 9396508
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
    Rozen R
    Thromb Haemost; 1997 Jul; 78(1):523-6. PubMed ID: 9198208
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperhomocysteinemia and C677T mutation of methylenetetrahydrofolate reductase].
    Grasa Ullrich JM; Torres Gómez M; Sánchez Marín B; Calvo Martín MT; García Erce JA; Giralt Raichs M
    An Med Interna; 2002 May; 19(5):269. PubMed ID: 12108010
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients.
    Morimoto K; Haneda T; Okamoto K; Ishida H; Kikuchi K
    Nephron; 2002 Jan; 90(1):43-50. PubMed ID: 11744804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
    Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common methylenetetrahydrofolate reductase gene mutation and longevity.
    Brattström L; Zhang Y; Hurtig M; Refsum H; Ostensson S; Fransson L; Jonés K; Landgren F; Brudin L; Ueland PM
    Atherosclerosis; 1998 Dec; 141(2):315-9. PubMed ID: 9862180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase gene polymorphism and coronary artery disease in Taiwan Chinese.
    Chen TY; Chen JH; Tsao CJ
    Haematologica; 2000 Apr; 85(4):445-6. PubMed ID: 10756383
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperhomocysteinemia: another independent vascular risk factor.
    Deleu D
    Saudi Med J; 2000 Aug; 21(8):787-8. PubMed ID: 11423902
    [No Abstract]   [Full Text] [Related]  

  • 14. Two mutations in the MTHFR gene associated with mild hyperhomocysteinaemia.
    Tikly M; Zannettou N; Traub B
    S Afr Med J; 2003 Mar; 93(3):161-2. PubMed ID: 12768933
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic basis of hyperhomocysteinemia.
    Medina MA; Amores-Sánchez MI
    Mol Genet Metab; 2000 Nov; 71(3):478-80. PubMed ID: 11073715
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension.
    Garfunkel VA; Porto PI; Garcia SI; Dieuzeide G; Kirszner T; Plotquin Y; Spataro RJ; Gonzalez C; Pirola CJ
    J Hum Hypertens; 2003 May; 17(5):361-4. PubMed ID: 12756410
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic modulation of homocysteinemia.
    Rozen R
    Semin Thromb Hemost; 2000; 26(3):255-61. PubMed ID: 11011843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate reductase mutation and coronary artery disease.
    Samani NJ
    Circulation; 1998 Dec 22-29; 98(25):2932-3. PubMed ID: 9860798
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The homocysteine confusion: now, more is better?
    Canavese C; Messuerotti A; Fenoglio R; Mesiano P; Massarenti P; Pauletto D; Aimo G; Priolo G
    Kidney Int; 2002 May; 61(5):1907-8; author reply 1908-9. PubMed ID: 11967046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.